MediPharm Labs Sets Date to Release Third Quarter 2020 Financial Results

TORONTO, Oct. 28, 2020 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE:MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, is pleased to announce it will release third quarter financial results for the three and nine month period ended September 30, 2020 before markets openContinue reading “MediPharm Labs Sets Date to Release Third Quarter 2020 Financial Results”

Neptune Wellness Solutions Inc. Secures Supply Agreement with Ontario Cannabis Store (OCS), Extends Company’s Canadian Footprint to 515 Retailers

~ The deal represents the second major province to ink such an agreement with the Company for its proprietary Mood Ring cannabis line for the Canadian market ~ LAVAL, QC, Oct. 27, 2020 /CNW Telbec/ – Neptune Wellness Solutions, Inc. (“Neptune” or the “Company”) (NASDAQ: NEPT) (TSX: NEPT) has entered into a supply agreement with the Ontario Cannabis StoreContinue reading “Neptune Wellness Solutions Inc. Secures Supply Agreement with Ontario Cannabis Store (OCS), Extends Company’s Canadian Footprint to 515 Retailers”

Lexaria Bioscience Granted First European Patent for DehydraTECH Technology

Lexaria Bioscience Corp. announced that it is receiving its first-ever granted patent in Europe related to its DehydraTECHTM technology.

Tetra Bio-Pharma Acquires Exclusive Global Technology Rights to a Mucoadhesive Delivery Technology Called Adversa(R) for its PPP-002 (dronabinol) drug candidate from IntelGenx

Tetra will leverage its recent Dronabinol data pack acquisition to rapidly file its second New Drug Submission application to commercialize another THC-based prescription drug Further reinforces its patent protection and life cycle management on its dronabinol franchise Shown in a clinical trial to have fewer side effects and enhanced bioavailability Solidifies Tetra’s revenue stream OTTAWA,Continue reading “Tetra Bio-Pharma Acquires Exclusive Global Technology Rights to a Mucoadhesive Delivery Technology Called Adversa(R) for its PPP-002 (dronabinol) drug candidate from IntelGenx”

Avicanna Announces Results of Annual General and Special Meeting

TORONTO, Oct. 20, 2020 /CNW/ – Avicanna Inc. (“Avicanna” or the “Company“) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing and commercialization of cannabinoid-based products, is pleased to announce that all of management’s nominees listed in the Company’s management information circular dated September 22, 2020 were elected as directors of the Company at Avicanna’s annualContinue reading “Avicanna Announces Results of Annual General and Special Meeting”

Meta Growth Announces Strong Support and Board Nominees in Connection with Proposed Arrangement with High Tide

TORONTO, Oct. 21, 2020 /CNW/ – Meta Growth Corp. (TSXV: META) (“Meta Growth”, “META” or the “Company”) is pleased to announce that in connection with the previously announced proposed acquisition pursuant to which High Tide Inc. (“High Tide”) will acquire all of the issued and outstanding common shares of META (“META Shares”) by way of a plan of arrangementContinue reading “Meta Growth Announces Strong Support and Board Nominees in Connection with Proposed Arrangement with High Tide”

4Front Ventures Corp. Announces C$15 Million Bought Deal Public Offering

PHOENIX, Oct. 20, 2020 /CNW/ – 4Front Ventures Corp. (“4Front” or the “Company“) (CSE: FFNT) (OTCQX: FFNTF) is pleased to announce that it has entered into an agreement with Beacon Securities Limited (“Beacon” or the “Lead Underwriter“), on behalf of a syndicate of underwriters (together with the Lead Underwriter, the “Underwriters“), pursuant to which the Underwriters have agreedContinue reading “4Front Ventures Corp. Announces C$15 Million Bought Deal Public Offering”

Delta 9 Announces Normal Course Issuer Bid for Common Shares and Convertible Debentures

WINNIPEG, Manitoba, Oct. 20, 2020 (GLOBE NEWSWIRE) — DELTA 9 CANNABIS INC. (TSX: DN) (OTCQX: VRNDF) (“Delta 9” or the “Company”) today announced that the Toronto Stock Exchange (“TSX”) has approved the Company’s normal course issuer bid (the “NCIB”). Under the NCIB, the Company can purchase: (i) up to an aggregate of 2,802,503 common sharesContinue reading “Delta 9 Announces Normal Course Issuer Bid for Common Shares and Convertible Debentures”

1933 Industries Partners with Orchid Ventures to Launch the Orchid Essentials Brand in Nevada

VANCOUVER – Oct. 20, 2020 – 1933 Industries Inc. (CSE: TGIF) (OTCQX: TGIFF), together with Orchid Ventures Inc. (CSE: ORCD) (OTC: ORVRF) (“Orchid”), are pleased to announce that they have entered into a Supply and Licensing Agreement (“Agreement”) for the manufacturing and distribution of Orchid products into the regulated Nevada cannabis market. Washington-based Orchid Ventures, Inc., through its wholly owned subsidiary,Continue reading “1933 Industries Partners with Orchid Ventures to Launch the Orchid Essentials Brand in Nevada”